Neurokinin A

Neurokinin A is an endogenous tachykinin agonist with preference for the NK-2R

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Neurokinin A(CAS 86933-74-6)

CAT No: 10-101-295

CAS No:86933-74-6

Synonyms/Alias:NEUROKININ A;86933-74-6;Neurokinin alpha;Substance K;Neuromedin L;Neurokinin A (alligator);Porcine neurokinin A;Neurokinin A (Python molurus);Neurokinin alpha (porcine);Neurokinin A (pig spinal cord);Neuromedin L (pig spinal cord);Neurokinin A (swine spinal cord);Neurokinin alpha (pig spinal cord);94168F9W1D;CHEMBL217406;Neurokinin A trifluoroacetate salt;DTXSID701027125;Kassinin, 1-de-L-aspartic acid-2-de-L-valine-3-L-histidine-5-L-threonine-7-L-serine-;His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2;L-Methioninamide, L-histidyl-L-lysyl-L-threonyl-L-alpha-aspartyl-L-seryl-L-phenylalanyl-L-valylglycyl-L-leucyl-;(5S,8S,14S,17S,20S,23S)-23-((2S,3R)-2-((S)-6-amino-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)hexanamido)-3-hydroxybutanamido)-17-benzyl-5-carbamoyl-20-(hydroxymethyl)-8-isobutyl-14-isopropyl-7,10,13,16,19,22-hexaoxo-2-thia-6,9,12,15,18,21-hexaazapentacosan-25-oic acid;L-HISTIDYL-L-LYSYL-L-THREONYL-L-.ALPHA.-ASPARTYL-L-SERYL-L-PHENYLALANYL-L-VALYLGLYCYL-L-LEUCYL-L-METHIONINAMIDE;L-METHIONINAMIDE, L-HISTIDYL-L-LYSYL-L-THREONYL-L-.ALPHA.-ASPARTYL-L-SERYL-L-PHENYLALANYL-L-VALYLGLYCYL-L-LEUCYL-;NKA;[125I]-neurokinin A;GTPL2089;GTPL3795;UNII-94168F9W1D;[125I]-NKA;DTXCID501511356;[125I]NKA (human, mouse, rat);BDBM50001447;-Neurokinin;Neuromedin L;Substance K;AKOS024456420;AKOS040763868;DA-76125;FN109083;TS-10268;G12445;His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH(2);His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2(NeurokininA);H-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2; H-HKTDSFVGLM-NH2;(3S)-3-[(2S,3R)-2-[(2S)-6-AMINO-2-[(2S)-2-AMINO-3-(1H-IMIDAZOL-4-YL)PROPANAMIDO]HEXANAMIDO]-3-HYDROXYBUTANAMIDO]-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-[({[(1S)-1-{[(1S)-1-CARBAMOYL-3-(METHYLSULFANYL)PROPYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}METHYL)CARBAMOYL]-2-METHYLPROPYL]CARBAMOYL}-2-PHENYLETHYL]CARBAMOYL}-2-HYDROXYETHYL]CARBAMOYL}PROPANOIC ACID;L-HISTIDYL-L-LYSYL-L-THREONYL-L-ALPHA-ASPARTYL-L-SERYL-L-PHENYLALANYL-L-VALYLGLYCYL-L-LEUCYL-L-METHIONINAMIDE;

Chemical Name:(3S)-3-[[(2S,3R)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C50H80N14O14S
M.W/Mr.
1133.3
Sequence
One Letter Code:HKTDSFVGLM
Three Letter Code:H-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2
Appearance
Powder
Purity
≥97% (HPLC)
Activity
Antibacterial, Antifungal

Neurokinin A, also known as substance K or NKA, is a member of the tachykinin family of neuropeptides that plays a significant role in neurotransmission and cellular signaling within the central and peripheral nervous systems. Characterized by its unique amino acid sequence and its affinity for neurokinin receptors—particularly the NK2 receptor—Neurokinin A is widely studied in the context of neurobiology, immunology, and gastrointestinal physiology. Its ability to modulate smooth muscle contraction, influence inflammatory pathways, and participate in pain perception underscores its relevance in a variety of research settings. As a bioactive peptide, Neurokinin A is valued by scientists aiming to unravel the complexities of neuropeptide-driven mechanisms in both health and disease models.

Neuroscience research: In the field of neuroscience, Neurokinin A serves as a powerful tool for investigating the mechanisms underlying synaptic transmission and neural communication. Researchers utilize NKA in in vitro and in vivo models to study its effects on neuronal excitability, neurotransmitter release, and modulation of synaptic plasticity. Its involvement in regulating the excitatory responses of neurons and its interaction with other neurotransmitter systems make it instrumental for elucidating the cellular basis of sensory processing, pain transmission, and neurogenic inflammation. The use of Neurokinin A analogs and receptor antagonists further enables detailed dissection of NK2-mediated signaling pathways, contributing to a deeper understanding of central and peripheral nervous system functions.

Gastrointestinal physiology: Neurokinin A is extensively employed in studies focused on gastrointestinal motility and function. As a potent stimulator of smooth muscle contraction, it provides a model for examining the regulation of gut peristalsis, secretion, and coordination of enteric reflexes. Experimental protocols often incorporate NKA to assess its role in the enteric nervous system and to explore interactions with other enteric neurotransmitters such as acetylcholine and serotonin. These investigations have advanced knowledge of gastrointestinal disorders, including irritable bowel syndrome and inflammatory bowel diseases, by clarifying how altered tachykinin signaling can impact gut motility and visceral sensitivity.

Respiratory system research: NKA is utilized in respiratory biology to explore its effects on airway smooth muscle tone, bronchoconstriction, and neurogenic inflammation. Studies involving animal models and isolated tissue preparations reveal that Neurokinin A contributes to airway hyperresponsiveness and mucus secretion, providing insights into the pathophysiology of conditions such as asthma and chronic obstructive pulmonary disease. By modulating the activity of airway nerves and immune cells, NKA enables researchers to probe the interplay between neural and immune mechanisms in respiratory health and disease.

Pain and nociception studies: The role of NKA in pain transmission and nociceptive signaling is a major focus of biomedical research. Scientists employ this peptide to dissect the molecular and cellular processes underlying acute and chronic pain states. Its action on NK2 receptors in sensory neurons facilitates the study of peripheral and central sensitization, neurogenic inflammation, and the cross-talk with other pain-mediating neuropeptides. The application of NKA in pain models aids in the identification of novel targets for the modulation of nociceptive pathways and the development of future pain management strategies.

Immunology and inflammation: Beyond its neural functions, Neurokinin A is increasingly recognized for its immunomodulatory properties. Research in immunology leverages NKA to explore its capacity to influence cytokine production, leukocyte migration, and the activation of immune cells such as mast cells and macrophages. These studies shed light on the role of tachykinin signaling in the orchestration of inflammatory responses, tissue repair, and the progression of immune-mediated diseases. By understanding how NKA interacts with immune pathways, scientists can better characterize the complex neuroimmune axis and its implications for physiological and pathological processes.

Ongoing research continues to expand the applications of Neurokinin A across diverse scientific domains. Its multifaceted biological actions make it a valuable peptide for probing neuropeptide signaling networks, dissecting organ system physiology, and elucidating the intricate interplay between the nervous and immune systems. As investigators develop more refined experimental models and analytical techniques, Neurokinin A remains at the forefront of efforts to decode the molecular underpinnings of neural, gastrointestinal, respiratory, pain, and immune functions, driving innovation and discovery in fundamental and translational research.

Length
10
Long-term Storage Conditions
Soluble to 1 mg/ml in water
Shipping Condition
Wet ice in continental US; may vary elsewhere
InChI
InChI=1S/C50H80N14O14S/c1-26(2)18-34(45(73)58-32(42(53)70)15-17-79-6)57-38(67)23-55-49(77)40(27(3)4)63-47(75)35(19-29-12-8-7-9-13-29)60-48(76)37(24-65)62-46(74)36(21-39(68)69)61-50(78)41(28(5)66)64-44(72)33(14-10-11-16-51)59-43(71)31(52)20-30-22-54-25-56-30/h7-9,12-13,22,25-28,31-37,40-41,65-66H,10-11,14-21,23-24,51-52H2,1-6H3,(H2,53,70)(H,54,56)(H,55,77)(H,57,67)(H,58,73)(H,59,71)(H,60,76)(H,61,78)(H,62,74)(H,63,75)(H,64,72)(H,68,69)/t28-,31+,32+,33+,34+,35+,36+,37+,40+,41+/m1/s1
InChI Key
HEAUFJZALFKPBA-JPQUDPSNSA-N
Canonical SMILES
CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CCCCN)NC(=O)C(CC2=CN=CN2)N
Isomeric SMILES
C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CN=CN2)N)O

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide Analysis ServicesPeptide Synthesis ServicesPeptide CDMOCustom Conjugation ServiceEpitope Mapping ServicesPeptide Nucleic Acids SynthesisPeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers